A View on EGFR-targeted Therapies From the Oncogene-Addiction Perspective

Frontiers in Pharmacology - Switzerland
doi 10.3389/fphar.2013.00053
Full Text
Abstract

Available in full text

Categories
Pharmacology
Date
Authors
Publisher

Frontiers Media SA

Related search

MA27.10 EGFR-Targeted Therapy Alters the Tumor Microenvironment in EGFR-Driven Lung Tumors: Rationale for Combination Therapies

Journal of Thoracic Oncology
MedicineOncologyRespiratory MedicinePulmonary
2018English

From Biochemical Analysis to Targeted Therapies

Fibrogenesis and Tissue Repair
DermatologyMedicineHepatologyRheumatologyGastroenterology
2012English

An FDA Perspective on the Regulatory Implications of Complex Signatures to Predict Response to Targeted Therapies

Clinical Cancer Research
Cancer ResearchOncology
2016English

Targeted Cancer Therapies

Chinese Journal of Cancer
2011English

Recognizing the Challenges of Oncogene Fusion Detection: A Critical Step Toward Optimal Selection of Lung Cancer Patients for Targeted Therapies

Journal of Thoracic Oncology
MedicineOncologyRespiratory MedicinePulmonary
2018English

Thymic Malignancies: From Clinical Management to Targeted Therapies

Journal of Clinical Oncology
Cancer ResearchMedicineOncology
2011English

Whom to Screen? A View on Lung Cancer Screening From the Pneumologist’s Perspective

Memo - Magazine of European Medical Oncology
OncologyHematology
2019English

New Perspectives on Biological HDL-targeted Therapies

Expert Opinion on Biological Therapy
Drug DiscoveryClinical BiochemistryPharmacology
2017English

Bell’s Palsy in Singapore: A View From the Patient’s Perspective

Singapore Medical Journal
Medicine
2013English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy